Cervical Health

We offer a comprehensive cervical cancer screening portfolio, from sample collection to diagnosis. Our leading technologies provide effective, robust and proven end-to-end solutions that meet the needs of all commonly used national cervical cancer screening programs.

Graphic showing connection between Hologic products

A Total Screening Solution

We pride ourselves on being champions of women’s health and global leaders in screening, dedicated to advancing the accuracy and early detection of cervical cancer. We bring clinical confidence and workflow efficiency to labs and clinicians through our market-leading ThinPrep® Pap test and Aptima HPV assay. We are also pushing the boundaries of cytology with the new GeniusTM Digital Diagnostics System.

Advancing Precision Detection Together

We provide the information that healthcare providers need to guide earlier detection of cervical cancer and consequently make better treatment decisions for their patients.

For more than 30 years, our expert team of cervical health scientists, engineers, application specialists and customer service managers have been chosen and trusted to support the delivery of regional and national cervical screening programmes throughout the world.

Lab technician looking and pointing to monitor screen in lab setting
    1. Aptima HPV Assay [package insert] AW-22202 Rev 001. San Diego, CA: Hologic, Inc.; 2023
    2. Genius Digital Diagnostics_CE Mark Press Release_FINAL_11.15.20


    Hologic BV, DA Vincilaan 5, 1930 Zaventem, Belgium

    Notified Body number wherever applicable